Breast cancer deaths in the US continue to fall, but new report …
网页5 天之前 · The study, published Tuesday in CA: A Cancer Journal for Clinicians, found some good news: The overall breast cancer death rate in the US dropped about 44% between 1989 and 2022, which...
Press Releases - pressroom.cancer.org
网页6 天之前 · Breast cancer is the most common cancer among U.S. women after skin cancer and the leading cause of cancer death in Hispanic women. In 2024, a n estimated 310,720 new cases of invasive breast cancer will be diagnosed in women, and approximately 42,250 women are expected to die from the disease.
Breast Cancer News - ScienceDaily
网页3 天之前 · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
Breast Cancer Incidence Still Rises and Death Rate Still Declines
网页5 天之前 · A new American Cancer Society (ACS) report finds that the incidence of breast cancer in women has continued to increase, rising by 1% a year during 2012 to 2021, for all women combined.
New study finds triple-negative breast cancer tumors with an …
网页2024年4月25日 · By Kelley Luckstein. A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
Estrogen a more powerful breast cancer culprit than we realized
网页2023年5月17日 · The findings suggest that estrogen-suppressing drugs such as tamoxifen — often given to patients with breast cancer to prevent disease recurrence — work in a more direct manner than simply reducing breast cell proliferation.
Breast cancer - Latest research and news | Nature
网页2024年9月30日 · Breast cancer - Latest research and news | Nature. Breast cancer articles from across Nature Portfolio. Breast cancer is caused by the development of malignant cells in the breast. The...
FDA expands approval of breast cancer drug Kisqali - NBC New …
网页2024年9月17日 · The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said...
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
网页2022年6月7日 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
Experimental immunotherapy targets metastatic breast cancer
网页2022年2月1日 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).